Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Comparative monitoring of oral theophylline treatment in blood serum, saliva, and nasal mucus.

Henkin RI.

Ther Drug Monit. 2012 Apr;34(2):217-21. doi: 10.1097/FTD.0b013e3182492a20.

PMID:
22377744
[PubMed - indexed for MEDLINE]
2.

Relative resistance to oral theophylline treatment in patients with hyposmia manifested by decreased secretion of nasal mucus cyclic nucleotides.

Henkin RI, Velicu I, Schmidt L.

Am J Med Sci. 2011 Jan;341(1):17-22. doi: 10.1097/MAJ.0b013e3181f1fdc8.

PMID:
21191261
[PubMed - indexed for MEDLINE]
3.

An open-label controlled trial of theophylline for treatment of patients with hyposmia.

Henkin RI, Velicu I, Schmidt L.

Am J Med Sci. 2009 Jun;337(6):396-406. doi: 10.1097/MAJ.0b013e3181914a97.

PMID:
19359985
[PubMed - indexed for MEDLINE]
4.

Intranasal theophylline treatment of hyposmia and hypogeusia: a pilot study.

Henkin RI, Schultz M, Minnick-Poppe L.

Arch Otolaryngol Head Neck Surg. 2012 Nov;138(11):1064-70. doi: 10.1001/2013.jamaoto.342.

PMID:
23165381
[PubMed - indexed for MEDLINE]
5.

Differences between and within human parotid saliva and nasal mucus cAMP and cGMP in normal subjects and in patients with taste and smell dysfunction.

Henkin RI, Velicu I.

J Oral Pathol Med. 2011 Jul;40(6):504-9. doi: 10.1111/j.1600-0714.2010.00986.x. Epub 2010 Dec 17.

PMID:
21166719
[PubMed - indexed for MEDLINE]
6.

Interleukin 6 in hyposmia.

Henkin RI, Schmidt L, Velicu I.

JAMA Otolaryngol Head Neck Surg. 2013 Jul;139(7):728-34. doi: 10.1001/jamaoto.2013.3392.

PMID:
23868430
[PubMed - indexed for MEDLINE]
7.

Aetiological relationships of nasal mucus cyclic nucleotides in patients with taste and smell dysfunction.

Henkin RI, Velicu I.

J Clin Pathol. 2012 May;65(5):447-51. doi: 10.1136/jclinpath-2012-200698. Epub 2012 Feb 22.

PMID:
22362840
[PubMed - indexed for MEDLINE]
8.

Theophylline induces changes in the electro-olfactogram of the mouse.

Gudziol V, Pietsch J, Witt M, Hummel T.

Eur Arch Otorhinolaryngol. 2010 Feb;267(2):239-43. doi: 10.1007/s00405-009-1076-7.

PMID:
19727789
[PubMed - indexed for MEDLINE]
9.

Efficacy of exogenous oral zinc in treatment of patients with carbonic anhydrase VI deficiency.

Henkin RI, Martin BM, Agarwal RP.

Am J Med Sci. 1999 Dec;318(6):392-405.

PMID:
10616164
[PubMed - indexed for MEDLINE]
10.

Theophylline concentrations in serum and saliva after oral microcrystalline and sustained-release preparations in asthmatics.

Munch EP, Søndergaard I, Weeke B.

Allergy. 1981 Feb;36(2):89-98.

PMID:
7235205
[PubMed - indexed for MEDLINE]
11.

Comparative pharmacokinetic analysis of theophylline in serum and saliva.

Trnavská Z, Rejholec V, Elis J, Spicák V.

Int J Clin Pharmacol Res. 1987;7(5):329-35.

PMID:
3667005
[PubMed - indexed for MEDLINE]
12.

cAMP and cGMP in nasal mucus related to severity of smell loss in patients with smell dysfunction.

Henkin RI, Velicu I.

Clin Invest Med. 2008;31(2):E78-84.

PMID:
18377764
[PubMed - indexed for MEDLINE]
13.

Compliance of chronic asthmatics with oral administration of theophylline as measured by serum and salivary levels.

Eney RD, Goldstein EO.

Pediatrics. 1976 Apr;57(4):513-7.

PMID:
1264547
[PubMed - indexed for MEDLINE]
14.

Etiological relationships of parotid saliva cyclic nucleotides in patients with taste and smell dysfunction.

Henkin RI, Velicu I.

Arch Oral Biol. 2012 Jun;57(6):670-7. doi: 10.1016/j.archoralbio.2012.01.004. Epub 2012 Feb 4.

PMID:
22310165
[PubMed - indexed for MEDLINE]
15.

Intranasal insulin: from nose to brain.

Henkin RI.

Nutrition. 2010 Jun;26(6):624-33. doi: 10.1016/j.nut.2009.08.003. Epub 2009 Dec 22.

PMID:
20022470
[PubMed - indexed for MEDLINE]
16.

Theophylline in oral mucosal transudate. A practical method for monitoring outpatient therapy.

Holden WE, Bartos F, Theime T, Green TR, Fitchen JH.

Am Rev Respir Dis. 1993 Mar;147(3):739-43.

PMID:
8442610
[PubMed - indexed for MEDLINE]
17.

Therapeutic drug monitoring of theophylline in frail elderly patients: oral compared with nasogastric tube administration.

Berkovitch M, Dafni O, Leiboviz A, Mayan H, Habut B, Segal R.

Ther Drug Monit. 2002 Oct;24(5):594-7.

PMID:
12352930
[PubMed - indexed for MEDLINE]
18.

Increased brain activation in response to odors in patients with hyposmia after theophylline treatment demonstrated by fMRI.

Levy LM, Henkin RI, Lin CS, Hutter A, Schellinger D.

J Comput Assist Tomogr. 1998 Sep-Oct;22(5):760-70.

PMID:
9754114
[PubMed - indexed for MEDLINE]
19.

MK-0873, a PDE4 inhibitor, does not influence the pharmacokinetics of theophylline in healthy male volunteers.

Boot JD, De Haas SL, Van Gerven JM, De Smet M, Leathem T, Wagner J, Denker A, Miller D, Van Doorn MB, Schoemaker RC, Cohen AF, Diamant Z.

Pulm Pharmacol Ther. 2008;21(3):573-7. doi: 10.1016/j.pupt.2008.01.009. Epub 2008 Feb 3.

PMID:
18321743
[PubMed - indexed for MEDLINE]
20.

Serum/saliva correlations for theophylline in asthmatics.

Blanchard J, Harvey S, Morgan WJ.

J Clin Pharmacol. 1991 Jun;31(6):565-70.

PMID:
1880223
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk